# Tcm Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tcm-technology

- Industry: Healthcare
- Headquarters: Tianjin, China
- Website: www.cntmic.com
- Latest round: Series B (Mar 10, 2026)
- Investors on record: 2

## About

Based in Tianjin, China, Tcm Technology specializes in innovative solutions across the Traditional Chinese Medicine industry, focusing on modernization and internationalization to improve health outcomes.Tcm Technology, officially known as Tianjin Modern Innovation Traditional Chinese Medicine Co., Ltd., was founded in 2017 in Tianjin, China. The company is focused on advancing the Traditional Chinese Medicine (TCM) sector through modern practices. In March 2026, the company raised an undisclosed amount of Series B funding from Renai Capital to further support its initiatives. The firm has completed a total of 2 deals, with the most recent deal dated March 10, 2026.Tcm Technology focuses on the comprehensive innovation across the entire Traditional Chinese Medicine (TCM) industry chain. Their core offerings encompass a range of products and services aimed at enhancing health outcomes through TCM principles, utilizing advanced technology in areas such as herbal medicine and related therapies. The company serves a global clientele, including healthcare providers, research institutions, and educational entities, with a focus on markets in Asia, Europe, and North America, fostering collaboration among industry stakeholders to support TCM innovations.The revenue model of Tcm Technology is primarily based on B2B partnerships within the healthcare sector. The company engages in transactions involving TCM products and services for healthcare providers, including subscription-based access to proprietary formulations and technology platforms that facilitate TCM applications in modern healthcare. Additionally, the firm forms direct partnerships with research institutions and universities, focusing on collaborative research agreements and joint ventures for product development. Their flagship offerings are designed to meet the global demand for natural health products.Tcm Technology plans to leverage recent funding from the Series B round in March 2026 to expand its product offerings and enhance its market presence. The company aims to introduce new TCM products aimed at fulfilling the growing demand for natural health solutions, with specific launches scheduled for 2026. Additionally, Tcm Technology is targeting expansion into North American and European markets by 2027, with a strategy to establish partnerships that will facilitate the introduction of their innovative TCM products in these regions.

## Funding rounds

- Series B, Mar 10, 2026 — Renai Capital
- Series A, May 22, 2019 — Tianjin Tasly Venture Capital

## Investors

- Tianjin Tasly Venture Capital (https://capitalatlas.ai/funds/tianjin-tasly-venture-capital) — Series A
- Renai Capital (https://capitalatlas.ai/funds/renai-capital) — Series B